Naloxone Hydrochloride Injection, Solution
Product Images NDC 43066-142

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 43066-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01-naloxone-structure (Image 01 Naloxone Structure)

Chemical structure of naloxone hydrochloride dihydrate, illustrating its molecular arrangement with associated hydrochloride and water components.*

FDA Label Image

Image-02-figure (Image 02 Figure)

Naloxone HCl Injection, USP 2 mg/2 mL is shown with packaging and a prefilled syringe. The label indicates use for intravenous, intramuscular, or subcutaneous administration. The product is by Baxter Healthcare Corporation, labeled with NDC 43066-142-01. The carton displays dosing information and a discard date area.*

FDA Label Image

Image-03-figure-2a-2b (Image 03 Figure 2a 2b)

An instructional illustration showing hands manipulating a syringe and vial. Figure 2a demonstrates removing a cap from the syringe and securing the vial, while Figure 2b shows twisting and pulling the syringe plunger inside the vial. The images depict steps in preparing a naloxone hydrochloride injection solution for use.*

FDA Label Image

Image-04-figure-3 (Image 04 Figure 3)

An instructional illustration showing two hands holding a syringe. One hand grips the syringe barrel while the other twists the syringe cap, indicated by a curved arrow, demonstrating how to remove the cap from the syringe prior to use.*

FDA Label Image

Image-05-figure-4 (Image 05 Figure 4)

A black and white line illustration showing a hand holding a prefilled syringe. The syringe has measurement markings up to 2 mL on the barrel and a plunger at the bottom, indicating a solution intended for injection.*

FDA Label Image

Image-06-syringe-label-2ml (Image 06 Syringe Label 2ml)

Label for Naloxone HCl injection, USP, showing 2 mg/2 mL dosage strength (1 mg/mL concentration) in a single-dose disposable prefilled syringe. The label indicates use for intravenous, intramuscular, or subcutaneous administration. It includes measurement markings up to 2 mL, barcode, lot and expiration placeholders, and is labeled by Baxter Healthcare Corporation, made in India.*

FDA Label Image

Image-07-mono-carton-2ml (Image 07 Mono Carton 2ml)

Naloxone HCl Injection, USP prefilled syringe packaging label showing 2 mg/2 mL (1 mg/mL) strength for intravenous, intramuscular, or subcutaneous use. Manufactured by Gland Pharma Limited for Baxter Healthcare Corporation. The label includes syringe assembly directions, storage conditions, and notes that no needle is included. The package contains a single-dose 2 mL disposable prefilled syringe.*

FDA Label Image

Image-08-outer-carton-2ml (Image 08 Outer Carton 2ml)

Naloxone HCl Injection, USP 2 mg/2 mL (1 mg/mL) single-dose disposable prefilled syringes packaging label by Baxter Healthcare Corporation. The label states use for intravenous, intramuscular, or subcutaneous administration as an opioid antagonist. It includes storage instructions and notes that no needle is included. Manufactured by Gland Pharma Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.